Padial A, Antunez C, Blanca-Lopez N, Fernandez T D, Cornejo-Garcia J A, Mayorga C, Torres M J, Blanca M
Clinica Norsalud, Madrid, Spain.
Clin Exp Allergy. 2008 May;38(5):822-8. doi: 10.1111/j.1365-2222.2008.02961.x. Epub 2008 Mar 6.
beta-Lactam (BL) antibiotics can induce non-immediate skin reactions, frequently manifested as exanthema or urticaria. The time between drug intake and the reaction appearance is generally 24-48 h. Because the mechanisms involved are not completely understood, diagnostic tests for these reactions have still to be fully validated.
To evaluate the role of skin and drug provocation tests (DPTs) in the diagnosis of patients with non-immediate reactions to BL.
We evaluated a group of 22 patients who developed maculopapular exanthema or urticarial exanthema after BL intake. Diagnosis was confirmed by DPT with BL. Intradermal/patch testing was performed with benzylpenicilloyl, minor determinant mixture, amoxicillin (AX), ampicillin (AMP) and the culprit drug in patients and in 22 negative controls. Immunohistochemical studies were done in the affected skin at the acute phase of the reaction and after a delayed positive skin test/DPT. IFN-gamma and IL-4 were quantified in peripheral mononuclear cells, obtained during the positive response to DPT and after resolution of the symptoms.
From the total number of cases, 12 patients developed urticarial exanthema and 10 maculopapular exanthema after DPT. Only two of the 22 patients (9%) had a positive delayed intradermal skin test: one to AX/AMP and the other to cloxacillin. Biopsies showed a mononuclear CD4, CD8 infiltrate and activated and memory cells. The cytokine expression showed a Th1 pattern in patients, in contrast with the Th0 pattern in controls.
In patients with non-immediate reactions to BLs (maculopapular exathema or urticarial exanthema), the sensitivity of skin testing is low and DPT may be required to establish the diagnosis. The reproducibility of the reactions and the cytokine pattern expressed during the acute episode support a T cell-induced non-immediate response.
β-内酰胺(BL)类抗生素可诱发非即时性皮肤反应,常表现为皮疹或荨麻疹。服药与反应出现之间的时间一般为24 - 48小时。由于其中涉及的机制尚未完全明确,针对这些反应的诊断测试仍有待充分验证。
评估皮肤和药物激发试验(DPT)在诊断对BL有非即时性反应患者中的作用。
我们评估了一组22例在服用BL后出现斑丘疹或荨麻疹样皮疹的患者。通过BL激发试验确诊。对患者及22名阴性对照者进行了苄青霉素酰、次要决定簇混合物、阿莫西林(AX)、氨苄西林(AMP)及可疑药物的皮内/斑贴试验。在反应急性期及皮肤试验/DPT延迟阳性后,对受累皮肤进行免疫组织化学研究。在DPT阳性反应期间及症状消退后,对外周血单个核细胞中的γ干扰素和白细胞介素-4进行定量分析。
在所有病例中,12例患者在DPT后出现荨麻疹样皮疹,10例出现斑丘疹。22例患者中仅有2例(9%)皮内试验延迟阳性:1例对AX/AMP阳性,另1例对氯唑西林阳性。活检显示有单核细胞CD4、CD8浸润以及活化和记忆细胞。细胞因子表达在患者中呈Th1模式,与对照中的Th0模式相反。
对于对BL有非即时性反应(斑丘疹或荨麻疹样皮疹)的患者,皮肤试验的敏感性较低,可能需要进行DPT以明确诊断。反应的可重复性以及急性期表达的细胞因子模式支持T细胞介导的非即时性反应。